182 related articles for article (PubMed ID: 11513878)
1. Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone.
Lage H; Perlitz C; Abele R; Tampé R; Dietel M; Schadendorf D; Sinha P
FEBS Lett; 2001 Aug; 503(2-3):179-84. PubMed ID: 11513878
[TBL] [Abstract][Full Text] [Related]
2. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Stein U; Scheffer GL; Lage H
Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
[TBL] [Abstract][Full Text] [Related]
5. Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.
Tönnies H; Poland J; Sinha P; Lage H
Int J Cancer; 2003 Mar; 103(6):752-8. PubMed ID: 12516094
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux.
Volk EL; Rohde K; Rhee M; McGuire JJ; Doyle LA; Ross DD; Schneider E
Cancer Res; 2000 Jul; 60(13):3514-21. PubMed ID: 10910063
[TBL] [Abstract][Full Text] [Related]
7. Functional cysteine-less subunits of the transporter associated with antigen processing (TAP1 and TAP2) by de novo gene assembly.
Heintke S; Chen M; Ritz U; Lankat-Buttgereit B; Koch J; Abele R; Seliger B; Tampé R
FEBS Lett; 2003 Jan; 533(1-3):42-6. PubMed ID: 12505156
[TBL] [Abstract][Full Text] [Related]
8. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA
J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941
[TBL] [Abstract][Full Text] [Related]
9. A multidrug resistance transporter from human MCF-7 breast cancer cells.
Doyle LA; Yang W; Abruzzo LV; Krogmann T; Gao Y; Rishi AK; Ross DD
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15665-70. PubMed ID: 9861027
[TBL] [Abstract][Full Text] [Related]
10. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Wichert A; Holm PS; Dietel M; Lage H
Cancer Gene Ther; 2001 Mar; 8(3):185-92. PubMed ID: 11332989
[TBL] [Abstract][Full Text] [Related]
11. Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.
Antoniou AN; Ford S; Pilley ES; Blake N; Powis SJ
Immunology; 2002 Jun; 106(2):182-9. PubMed ID: 12047747
[TBL] [Abstract][Full Text] [Related]
12. Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1.
Ritz U; Drexler I; Sutter D; Abele R; Huber C; Seliger B
J Immunol; 2003 Jan; 170(2):941-6. PubMed ID: 12517960
[TBL] [Abstract][Full Text] [Related]
13. Head-head/tail-tail relative orientation of the pore-forming domains of the heterodimeric ABC transporter TAP.
Vos JC; Reits EA; Wojcik-Jacobs E; Neefjes J
Curr Biol; 2000 Jan; 10(1):1-7. PubMed ID: 10660295
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
Liu F; Fan D; Qi J; Zhu H; Zhou Y; Yang C; Zhu Z; Xiong D
Life Sci; 2008 Sep; 83(13-14):496-501. PubMed ID: 18725232
[TBL] [Abstract][Full Text] [Related]
15. Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.
Priebsch A; Rompe F; Tönnies H; Kowalski P; Surowiak P; Stege A; Materna V; Lage H
Oligonucleotides; 2006; 16(3):263-74. PubMed ID: 16978089
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
18. Catalytic site modifications of TAP1 and TAP2 and their functional consequences.
Perria CL; Rajamanickam V; Lapinski PE; Raghavan M
J Biol Chem; 2006 Dec; 281(52):39839-51. PubMed ID: 17068338
[TBL] [Abstract][Full Text] [Related]
19. Biogenesis of functional antigenic peptide transporter TAP requires assembly of pre-existing TAP1 with newly synthesized TAP2.
Keusekotten K; Leonhardt RM; Ehses S; Knittler MR
J Biol Chem; 2006 Jun; 281(26):17545-51. PubMed ID: 16624807
[TBL] [Abstract][Full Text] [Related]
20. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.
Kellner U; Hutchinson L; Seidel A; Lage H; Danks MK; Dietel M; Kaufmann SH
Int J Cancer; 1997 May; 71(5):817-24. PubMed ID: 9180151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
